ZYOMYX
Fremont · Founded 1998
About ZYOMYX
Zyomyx has a unique expertise in and passion for tackling difficult “outside-the-box” problems. Highly user-friendly, instrument-free point-of-care tests need to be designed with an advanced level of cartridge engineering and reagent stability, and aligned with aggressive cost targets. Zyomyx specializes in exactly these demanding product requirements. Our immediate focus is an advanced, but simple to use and inexpensive CD4 T-cell point-of-care test that will be launched globally and configured to especially meet the demanding specifications for use in low and middle income countries.
Company Facts
- Founded: 1998
- Legal name: ZYOMYX INC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $34.3M
- Last round: Grant (Mar 2014)
- Website: zyomyx.com
- Phone: +1 510-265-8000
Social Profiles
Canonical: https://fsome.com/organization/zyomyx-8330317 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.